The Patent Finder
US

Kappa Opioid Receptor Antagonists and Products and Methods Related Thereto

US 11,897,873 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Blackthorn Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Mar 16, 2038 · High confidence

Filed Jul 30, 2021 as application 17/390,531 · Granted Feb 13, 2024
Base term plus 63 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2018 2038
Clock starts
Mar 16, 2018
Term ends
Mar 16, 2038
Granted
Feb 13, 2024
base term Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
63
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,676,469, US 11,124,504.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 63 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 16, 2018, when application 15/924,119, the earliest non-provisional in its chain, was filed (this one was filed Jul 30, 2021)Mar 16, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+63 days, USPTO patent term adjustment recordMay 18, 2038High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,676,469, US 11,124,504)capped to Mar 16, 2038High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 16, 2038High confidence

This family

US 10,676,469In force
Mar 2038
Mar 2038
US 11,124,504In force
Mar 2038
Mar 2038
US 11,897,873this patent
Mar 2038
Mar 2038
Application 18/542,394Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 16, 2024
Reel 68318, frame 204
Blackthorn Therapeutics, Inc.Neumora Therapeutics, Inc.Merger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited